000150860 000__ 01635fam\a2200397\a\4500
000150860 001__ 150860
000150860 005__ 20220217103308.0
000150860 007__ he|amb|||bbua
000150860 008__ 930302s1989\\\\mdua\\\\bb\\\f100\0\eng\d
000150860 035__ $$a(OCoLC)ocm27654961
000150860 035__ $$9(IS)ACR3872
000150860 035__ $$9AAR6987SI
000150860 035__ $$a150860
000150860 040__ $$aMST$$cMST
000150860 043__ $$an-us---
000150860 049__ $$aISUM
000150860 0860_ $$aHE 20.8202:AC 7/3
000150860 090__ $$aRA644.A25$$bA347 1989
000150860 096__ $$aWD 308 A288 1989
000150860 24500 $$aAIDS and intravenous drug abuse among minorities$$h[microform].
000150860 260__ $$aRockville, MD :$$bU.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse,$$c1989.
000150860 300__ $$avi, 105 p. :$$bill. ;$$c23 cm.
000150860 440_0 $$aDHHS publication ;$$vno. (ADM) 89-1637
000150860 500__ $$aAt head of title: National Institute on Drug Abuse.
000150860 500__ $$aBased on papers presented at a meeting sponsored by the National Institute on Drug Abuse in Brooklyn, N.Y. in Dec. 1987.--Cf. t.p. verso.
000150860 504__ $$aIncludes bibliographical references.
000150860 533__ $$aMicrofiche.$$b[Washington] :$$cSupt Docs/GPO,$$d1989.$$e2  microfiche ; 11 x 15 cm.
000150860 539__ $$as$$b1989$$dmdu$$en
000150860 650_0 $$aAIDS (Disease)$$zUnited States$$vCongresses.
000150860 650_0 $$aMinorities$$zUnited States$$xDrug use$$vCongresses.
000150860 650_0 $$aMinorities$$xHealth and hygiene$$zUnited States$$vCongresses.
000150860 650_2 $$aAcquired Immunodeficiency Syndrome$$xcongresses
000150860 650_2 $$aSubstance Abuse$$xcongresses
000150860 650_2 $$aMinority Groups$$xcongresses
000150860 7102_ $$aNational Institute on Drug Abuse.
000150860 85230 $$bdfich$$hHE 20.8202:$$iAC 7/3
000150860 909CO $$ooai:library.usi.edu:150860$$pGLOBAL_SET
000150860 948__ $$ac:ajk
000150860 980__ $$aBIB
000150860 980__ $$aGOV RESOURCE